Skip to main content

Table 3 EZ-ALBI and ALBI score/grade at baseline and after TACE

From: Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

Scores and grade

Baseline (N = 163)

N (%)/ mean ± SD

Post-TACE (N = 145)

N (%)/ mean ± SD

p-value

EZ-ALBI score

− 37.70 ± 92.63

− 27.61 ± 5.51

0.185

EZ-ALBI grade

 -Grade 1

 -Grade 2

 -Grade 3

40 (24.5%)

114 (69.9%)

9 (5.5%)

16 (11.0%)

105 (72.4%)

24 (16.6%)

 

ALBI score

− 2.89 ± 8.76

− 1.93 ± 0.59

0.181

ALBI-grade

 -Grade 1

 -Grade 2

 -Grade 3

40 (24.6%)

111 (68.0%)

12 (7.4%)

18 (12.4%)

95 (65.5%)

32 (22.1%)

 
  1. ALBI Albumin-bilirubin, EZ-ALBI Easy albumin-bilirubin, N Number, SD Standard deviation, TACE Trans-arterial chemoembolization